Vivanza Biosciences News

Vivanza Biosciences Exempt from Secretarial Report

Vivanza Biosciences Limited announces non-applicability of Annual Secretarial Compliance Report for FY26 under SEBI Regulation 24A due to paid-up capital of Rs. 4 crore and net worth of Rs. 4,02,03,752.40.

Vivanza Biosciences Files Non-Applicability Statement

Vivanza Biosciences Limited confirms no fund raising activities, making SEBI LODR deviation statement non-applicable under Regulation 32.

Vivanza Biosciences Files SEBI SAST Disclosure

Vivanza Biosciences Limited and its promoters submit yearly disclosure under SEBI SAST Regulations 2011 for FY26, declaring shareholdings as of March 31, 2026.

Vivanza Biosciences confirms non-Large Corporate status

Vivanza Biosciences Limited confirms it does not fall under Large Corporate category as of March 31, 2026, exempting it from specific debt securities disclosure requirements for FY26.

Vivanza Biosciences Submits Q4 FY26 SEBI Certificate

Vivanza Biosciences Limited submitted its quarterly confirmation certificate under SEBI regulations for Q4 FY26, with no share certificates dematerialized during the period.